Ramulu Poddutoori
Inventor
Stats
- 13 US patents issued
- 26 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 13 US Patents Issued
- 26 US Applications Filed
- 167 Total Citation Count
- May 27, 2022 Most Recent Filing
- Mar 30, 2001 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| NOVARTIS AG | 2
2 2 1 | 2012
2014 2015 2017 |
| COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 1
2 4 | 2001
2003 2004 |
| AURIGENE DISCOVERY TECHNOLOGIES LIMITED | 1
| 2016
|
| The Scripps Research Institute | 2
6 2 1 1 | 2009
2012 2014 2016 2017 |
Inventor Addresses
| Address | Duration |
|---|---|
| Andhra Pradesh, IN | Mar 26, 02 - Oct 04, 05 |
| Bangalore, IN | Dec 13, 12 - Aug 22, 24 |
| Hyderabad, Andhra Pradesh, IN | Sep 30, 04 - Oct 06, 05 |
| Hyderabad, IN | Oct 05, 04 - Jun 06, 06 |
| Jammikunta, IN | Jul 06, 23 - Jul 06, 23 |
| Karimnagar, IN | Mar 01, 18 - Aug 10, 23 |
| Karnataka, IN | Jan 05, 16 - Jan 18, 24 |
| La Jolla, CA, US | Jan 14, 10 - Jan 28, 20 |
| Telangana Karimnagar, IN | Jul 25, 24 - Jul 25, 24 |
| Telangana, IN | Oct 10, 19 - Jan 19, 21 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 22 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 8 |
| C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0277,722 | 2024 | CANCER THERAPY USING A COMBINATION OF CDK7 INHIBITOR WITH AN ANTI-CANCER AGENT | 0 |
| 2024/0246,917 | 2024 | PROCESS FOR PREPARING A CDK INHIBITOR | 0 |
| 2024/0016,811 | 2024 | CANCER THERAPY USING A COMBINATION OF CDK7 INHIBITOR WITH AN ANTI-MICROTUBULE AGENT | 0 |
| 2023/0250,062 | 2023 | Substituted Heterocyclyl Derivatives as CDK Inhibitors | 0 |
| 2023/0212,142 | 2023 | Substituted 5-Cyclopropyl-1H-pyrazole-3-yl-amine Derivatives as Selective CDK12/13 Inhibitors | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.